Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.06.07.20125096: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Patients and samples: The Institutional Ethics Review Committee of Foshan Fourth Hospital, Foshan, China approved this study and the written informed consent was obtained from each patient.
Consent: Patients and samples: The Institutional Ethics Review Committee of Foshan Fourth Hospital, Foshan, China approved this study and the written informed consent was obtained from each patient.Randomization A few conjugates were randomly selected for examination by SDS-PAGE. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Peptide microarray … SciScore for 10.1101/2020.06.07.20125096: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Patients and samples: The Institutional Ethics Review Committee of Foshan Fourth Hospital, Foshan, China approved this study and the written informed consent was obtained from each patient.
Consent: Patients and samples: The Institutional Ethics Review Committee of Foshan Fourth Hospital, Foshan, China approved this study and the written informed consent was obtained from each patient.Randomization A few conjugates were randomly selected for examination by SDS-PAGE. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Peptide microarray fabrication: The peptide-BSA conjugates as well as S1 protein, RBD protein and N protein of SARS-CoV-2, along with the negative (BSA) and positive controls (anti-Human IgG and IgM antibody), were printed in triplicate on PATH substrate slide (Grace Bio-Labs, Oregon, USA) to generate identical arrays in a 1 × 7 subarray format using Super Marathon printer (Arrayjet, UK). anti-Human IgGsuggested: NoneIgMsuggested: NoneThe arrays were washed with 1×PBST and bound antibodies were detected by incubating with Cy3-conjugated goat anti-human IgG and Alexa Fluor 647-conjugated donkey anti-human IgM (Jackson ImmunoResearch, PA, USA), which were diluted for 1: 1,000 in 1×PBST. anti-human IgMsuggested: NoneAntibodies or isotype IgG control (Thermo Fisher Scientific, MA, USA) in DMEM supplemented with 10% fetal calf serum were incubated with pseudoviruses at 37C for 1 h and then the mixtures were added to monolayer Huh-7 cells (104 per well in 96-well plates). isotype IgGsuggested: NoneExperimental Models: Cell Lines Sentences Resources Huh-7 cells were subsequently lysed with 50 µl lysis reagent (Promega, WI, USA), and 30 µl of the lysates were transferred to 96-well Costar flat-bottom luminometer plates (Corning Costar, MA, USA) for the detection of relative light units using the Firefly Luciferase Assay Kit (Promega, WI, USA) and an Ultra 384 luminometer (Tecan, Switzerland). Huh-7suggested: NoneSoftware and Algorithms Sentences Resources Pearson correlation coefficient between two proteins or indicators and the corresponding p value was calculated by SPSS software under the default parameters. SPSSsuggested: (SPSS, RRID:SCR_002865)Cluster analysis was performed by pheatmap package in R4. pheatmapsuggested: (pheatmap, RRID:SCR_016418)Visualization of the structural details were processed by Pymol (https://pymol.org/2/). Pymolsuggested: (PyMOL, RRID:SCR_000305)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-